Plasma catecholamine concentrations in blood obtained simultaneously from the pulmonary and radial arteries of ten critically ill patients have been measured. The mean mixed venous concentrations of noradrenaline, adrenaline and dopamine were extremely high, noradrenaline 11.3 pmollml (SD 11.6), adrenaline 2.7 pmollml (SD 3.0) and dopamine 7. I pmollml (SD 12.3). An appreciable drop in the concentrations occurred as the blood passed from the pulmonary artery to the radial artery (mean fall 24. I, 29.7 and 45.8% respectively). Four patients receiving a therapeutic dopamine infusion were also studied and demonstrated similar trends in catecholamine concentrations. The results suggest a substantial pulmonary clearance mechanism for all three catecholamines.
The ability of the lungs to inactivate many vasoactive substances, thereby preventing their access to the systemic circulation, is a phenomenon which has considerable clinical bearing. Some substances, such as kinins and adenine nucleotides, are said to be destroyed by contact with the endothelial lining in the course of a single circulation through the pulmonary capillary bed. Others, such as noradrenaline, are thought to be metabolised intracellularly after uptake from plasma.' Sole et al. 2 examined the net pulmonary extraction of circulating catecholamines in healthy volunteers and in patients with pulmonary hypertension.
They concluded that approximately 25070 of the circulating noradrenaline was removed by the lungs in a single passage, while adrenaline and dopamine were not extracted. However, circulating catecholamine levels were within the normal range in their subjects. We have examined the pulmonary clearance of catecholamines in critically ill patients in whom circulating amine concentrations might be expected to be elevated.
PATIENTS AND METHODS Ten patients in the Intensive Care Unit at the Royal Adelaide Hospital (Table la) were initially studied. For therapeutic purposes, each patient had a Swan-Ganz catheter and a radial artery cannula in situ which permitted simultaneous pulmonary artery and radial artery sampling. These samples were collected in chilled heparinised tubes (lithium heparin 125 U/lO ml) which contained glutathione (5 mM). The samples were centrifuged and the plasma separated from cells. Samples were then deproteinised with an equal volume of 0.6 M perchloric acid containing EGT A (10 mM) and MgCl2 (1 mM), centrifuged again and the supernatant stored at -20 QC.
Four patients receiving intravenous infusions of dopamine (Table 1 b ) were also studied. The sampling procedure and experimental protocol was identical with that for the other ten patients.
Assay of catecholamines
Adrenaline, noradrenaline and dopamine were estimated using a modification of the radioenzymatic method of Da Prada and Zurcher. 3 ,4 With this method, each of these catecholamines was converted to its respective O-methylated derivative by catechol-Omethyltransferase (COMT) in the presence of 3H-S-adenosyl methionine. Tritiated, digoxin, frusemide, diazepam, !PPV f1ucloxacillin, gentamicin, ticarcillin, co-trimoxazole O-methylated amines were then extracted, purified and finally separated by thin-layer chromatography and their radioactivity determined. For each experimental run a standard curve was constructed for adrenaline, noradrenaline and dopamine. The concentration of each catecholamine in the test solution was calculated by comparison with the respective standard curve. Recovery of tritiated O-methylated standards ranged from 60 to 620/0 over the concentration range 0 to 300 pmollml. Samples outside of this range were diluted to 
RESULTS
The levels of adrenaline, noradrenaline and dopamine present in the blood samples obtained simultaneously from the pulmonary and radial arteries of the ten critically ill patients are shown in Table 2 . The concentration of all three catecholamines was significantly lower in the radial than in the pulmonary artery (Wilcoxon paired test, one tailed). The concentration of dopamine was 45.8% lower in the radial artery than in the pulmonary artery (p < 0.005), while adrenaline was 29.7% (p =0.01) and noradrenaline was 24.1 % lower (p < 0.01). These findings suggest extraction of all three catecholamines in their passage through the pulmonary circulation. However, there was no correlation between the percentage of extraction in the same patient of noradrenaline and adrenaline (Spearman rank correlation: rSt 0.26, dft 9, N.S.), or between adrenaline and dopamine (rS = 0.28, N.S.), or noradrenaline and dopamine (rS =0.33, N.S.).
The data on four additional patients receiving dopamine infusions supported the observation of a substantial extraction of all three catecholamines (Table 3 ). Even the high circulating levels of dopamine caused by the infusion did not substantially alter the extraction fraction, which was 32.7%. Comparison of percentage dopamine extractions of two groups did not show a significant difference (t = 1.19, 12 df, p > 0.2). Similarly, noradrenaline and adrenaline percentage extraction was not significantly different (t=0.82, 12 df, p > 0.4 and t=0.76, 12 df, p > 0.4, respectively). The results of this study indicate that critically ill patients requiring intensive care have high circulating levels of noradrenaline, adrenaline and dopamine up to ten times greater than those seen in normal subjects undergoing general anaesthesia. 4 This finding is not unexpected when one considers the nature of the clinical disorders being treated (Table 1) . The high levels probably reflect increased adrenal medullary and sympathetic nerve release of catecholamines. Our observations are consistent with those of Benedict and Grahame-Smith,5 who studied the plasma adrenaline and noradrenaline concentrations in patients with haemorrhagic, septicaemic or trauma-induced shock.
An important finding to emerge from our study was the removal of a significant percentage of the circulating catecholamine pool when blood samples taken simultaneously from the pulmonary and radial arteries were examined. This phenomenon was observed with all three catecholamines. Our results are therefore at variance with those of Sole et al. 2 who found a pulmonary extraction of noradrenaline and not the other two. The findings may represent a "clearance process" which becomes manifest when the circulating level of these substances is high, whereas the patients described by Sole et al. 2 had only modest levels of noradrenaline, adrenaline and dopamine in their plasma.
A similar extraction of all three catecholamines was found in our small group of patients receiving therapeutic dopamine infusion. It is interesting to note that in this latter group the percentage clearance of dopamine was sustained despite exceedingly high circulating levels, which infers that the extraction mechanism is not saturable. The finding that there was no difference between the percentage extraction of noradrenaline in the untreated patients and in those with dopamine infusion confirms that the mechanisms of extraction for noradrenaline and dopamine appear to be independent. The mechanisms for adrenaline and dopamine appear to be similarly independent. This is also consistent with the findings that there was no correlation between percentage extraction of one catecholamine and another in the same patient. Although the extraction of the circulating catecholamines is very probably occurring in the lungs, it is relevant to note that we sampled from pulmonary artery and radial artery. Thus, clearance of drug by the endocardium or the arterial endothelium could give a similar result. However, the limited exposed surface area of both these sites would mean that an extraordinarily avid clearance mechanism was operating at these sites.
Gillis,6 in reviewing the metabolism of vasoactive hormones by the lung, made reference to the fact that the site of noradrenaline uptake was distinct from that for 5-hydroxytryptamine. This distinction was postulated even when the circulating levels of t~ese two substances were in the normal range. Smce the levels of catecholamines dealt with in the present study far exceed those examined previously, our findings extend the information on catecholamine handling by the lung.
The pulmonary extraction of dopamine in patients treated intravenously with this drug has significant clinical impact, as variation in pulmonary extraction from 0 to 700/0 could alone account for almost a threefold difference in dose requirement. This agent is being used increasingly in the therapy of cardiogenic shock, and it is useful to know that up to twothirds of the administered dose reaching the pulmonary artery may be cleared before reaching the systemic circulation.
